Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 15-16/2021

23.03.2021 | position paper

2020 update of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGHTG) on the position statement of the ÖKG and ÖGHTG for transcatheter aortic valve implantation 2011

verfasst von: Gudrun Lamm, Matthias Hammerer, Uta C. Hoppe, Martin Andreas, Rudolf Berger, Ronald K. Binder, Nikolaos Bonaros, Georg Delle-Karth, Matthias Frick, Michael Grund, Bernhard Metzler, Thomas Neunteufl, Philipp Pichler, Albrecht Schmidt, Wilfried Wisser, Andreas Zierer, Rainald Seitelberger, Michael Grimm, Alexander Geppert, ÖKG and ÖGHTG

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 15-16/2021

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

This position statement is an update to the 2011 consensus statement of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGTHG) for transfemoral transcatheter aortic valve implantation.
Due to a number of recently published studies, broadening of indications and recommendations of medical societies and our own national developments, the ÖKG and the ÖGHTG wish to combine the 2017 ESC/EACTS guidelines for the management of valvular heart disease with a national position paper and to focus on certain details for the application in Austria. Thus, this position statement serves as a supplement and further interpretation of the international guidelines.
Literatur
1.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91. PubMedCrossRef Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91. PubMedCrossRef
2.
Zurück zum Zitat Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20. PubMedCrossRef Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20. PubMedCrossRef
3.
Zurück zum Zitat Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31. PubMedCrossRef Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31. PubMedCrossRef
4.
Zurück zum Zitat Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25. PubMedCrossRef Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25. PubMedCrossRef
5.
Zurück zum Zitat Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382:799–809. PubMedCrossRef Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382:799–809. PubMedCrossRef
6.
Zurück zum Zitat Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705. PubMedCrossRef Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705. PubMedCrossRef
7.
Zurück zum Zitat Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–15. PubMedCrossRef Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–15. PubMedCrossRef
8.
Zurück zum Zitat Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. 2016;31:3–10. PubMedCrossRef Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. 2016;31:3–10. PubMedCrossRef
9.
Zurück zum Zitat Makkar RR, Jilaihawi H, Mack M, Chakravarty T, Cohen DJ, Cheng W, et al. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. J Am Coll Cardiol. 2014;63:901–11. PubMedCrossRef Makkar RR, Jilaihawi H, Mack M, Chakravarty T, Cohen DJ, Cheng W, et al. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. J Am Coll Cardiol. 2014;63:901–11. PubMedCrossRef
10.
Zurück zum Zitat Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–7. PubMedCrossRef Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–7. PubMedCrossRef
11.
Zurück zum Zitat Beach JM, Mihaljevic T, Svensson LG, Rajeswaran J, Marwick T, Griffin B, et al. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2013;61:837–48. PubMedPubMedCentralCrossRef Beach JM, Mihaljevic T, Svensson LG, Rajeswaran J, Marwick T, Griffin B, et al. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2013;61:837–48. PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Czer LS, Gray RJ, Stewart ME, De Robertis M, Chaux A, Matloff JM. Reduction in sudden late death by concomitant revascularization with aortic valve replacement. J Thorac Cardiovasc Surg. 1988;95:390–401. PubMedCrossRef Czer LS, Gray RJ, Stewart ME, De Robertis M, Chaux A, Matloff JM. Reduction in sudden late death by concomitant revascularization with aortic valve replacement. J Thorac Cardiovasc Surg. 1988;95:390–401. PubMedCrossRef
13.
Zurück zum Zitat Goel SS, Agarwal S, Tuzcu EM, Ellis SG, Svensson LG, Zaman T, et al. Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation. 2012;125:1005–13. PubMedCrossRef Goel SS, Agarwal S, Tuzcu EM, Ellis SG, Svensson LG, Zaman T, et al. Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation. 2012;125:1005–13. PubMedCrossRef
14.
Zurück zum Zitat Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607. PubMedCrossRef Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607. PubMedCrossRef
15.
Zurück zum Zitat Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98. PubMedCrossRef Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98. PubMedCrossRef
16.
Zurück zum Zitat Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–15. PubMedCrossRef Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–15. PubMedCrossRef
17.
Zurück zum Zitat Nombela-Franco L, Ribeiro HB, Urena M, Allende R, Amat-Santos I, DeLarochelliere R, et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014;63:2643–58. PubMedCrossRef Nombela-Franco L, Ribeiro HB, Urena M, Allende R, Amat-Santos I, DeLarochelliere R, et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014;63:2643–58. PubMedCrossRef
18.
Zurück zum Zitat Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, et al. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013;112:272–9. PubMedCrossRef Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, et al. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013;112:272–9. PubMedCrossRef
19.
Zurück zum Zitat Chakravarty T, Van Belle E, Jilaihawi H, Noheria A, Testa L, Bedogni F, et al. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2015;115:942–9. PubMedCrossRef Chakravarty T, Van Belle E, Jilaihawi H, Noheria A, Testa L, Bedogni F, et al. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2015;115:942–9. PubMedCrossRef
20.
Zurück zum Zitat Diaz R, Hernandez-Vaquero D, Alvarez-Cabo R, Avanzas P, Silva J, Moris C, et al. Long-term outcomes of mechanical versus biological aortic valve prosthesis: systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2019;158:706–714.e18. PubMedCrossRef Diaz R, Hernandez-Vaquero D, Alvarez-Cabo R, Avanzas P, Silva J, Moris C, et al. Long-term outcomes of mechanical versus biological aortic valve prosthesis: systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2019;158:706–714.e18. PubMedCrossRef
21.
Zurück zum Zitat Puskas JD, Gerdisch M, Nichols D, Fermin L, Rhenman B, Kapoor D, et al. Anticoagulation and antiplatelet strategies after on‑X mechanical aortic valve replacement. J Am Coll Cardiol. 2018;71:2717–26. PubMedCrossRef Puskas JD, Gerdisch M, Nichols D, Fermin L, Rhenman B, Kapoor D, et al. Anticoagulation and antiplatelet strategies after on‑X mechanical aortic valve replacement. J Am Coll Cardiol. 2018;71:2717–26. PubMedCrossRef
22.
Zurück zum Zitat Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, et al. 3‑year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2565–74. PubMedCrossRef Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, et al. 3‑year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2565–74. PubMedCrossRef
23.
Zurück zum Zitat Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5‑year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477–84. PubMedCrossRef Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5‑year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477–84. PubMedCrossRef
24.
Zurück zum Zitat Sondergaard L, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers nordic aortic valve intervention randomized clinical trial. Circ Cardiovasc Interv. 2016;9(6):e3665. PubMedCrossRef Sondergaard L, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers nordic aortic valve intervention randomized clinical trial. Circ Cardiovasc Interv. 2016;9(6):e3665. PubMedCrossRef
25.
Zurück zum Zitat Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1‑year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–94. PubMedCrossRef Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1‑year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–94. PubMedCrossRef
26.
Zurück zum Zitat Sondergaard L, Ihlemann N, Capodanno D, Jorgensen TH, Nissen H, Kjeldsen BJ, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73:546–53. PubMedCrossRef Sondergaard L, Ihlemann N, Capodanno D, Jorgensen TH, Nissen H, Kjeldsen BJ, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73:546–53. PubMedCrossRef
27.
Zurück zum Zitat Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5‑year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2485–91. PubMedCrossRef Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5‑year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2485–91. PubMedCrossRef
28.
Zurück zum Zitat Siemieniuk RA, Agoritsas T, Manja V, Devji T, Chang Y, Bala MM, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ. 2016;354:i5130. PubMedPubMedCentralCrossRef Siemieniuk RA, Agoritsas T, Manja V, Devji T, Chang Y, Bala MM, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ. 2016;354:i5130. PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Vandvik PO, Otto CM, Siemieniuk RA, Bagur R, Guyatt GH, Lytvyn L, et al. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ. 2016;354:i5085. PubMedCrossRef Vandvik PO, Otto CM, Siemieniuk RA, Bagur R, Guyatt GH, Lytvyn L, et al. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ. 2016;354:i5085. PubMedCrossRef
30.
Zurück zum Zitat Carroll JD, Vemulapalli S, Dai D, Matsouaka R, Blackstone E, Edwards F, et al. Procedural experience for transcatheter aortic valve replacement and relation to outcomes: the STS/ACC TVT registry. J Am Coll Cardiol. 2017;70:29–41. PubMedCrossRef Carroll JD, Vemulapalli S, Dai D, Matsouaka R, Blackstone E, Edwards F, et al. Procedural experience for transcatheter aortic valve replacement and relation to outcomes: the STS/ACC TVT registry. J Am Coll Cardiol. 2017;70:29–41. PubMedCrossRef
31.
Zurück zum Zitat Wassef AWA, Rodes-Cabau J, Liu Y, Webb JG, Barbanti M, Munoz-Garcia AJ, et al. The learning curve and annual procedure volume standards for optimum outcomes of transcatheter aortic valve replacement: findings from an international registry. JACC Cardiovasc Interv. 2018;11:1669–79. PubMedCrossRef Wassef AWA, Rodes-Cabau J, Liu Y, Webb JG, Barbanti M, Munoz-Garcia AJ, et al. The learning curve and annual procedure volume standards for optimum outcomes of transcatheter aortic valve replacement: findings from an international registry. JACC Cardiovasc Interv. 2018;11:1669–79. PubMedCrossRef
33.
Zurück zum Zitat Bestehorn K, Eggebrecht H, Fleck E, Bestehorn M, Mehta RH, Kuck KH. Volume-outcome relationship with transfemoral transcatheter aortic valve implantation (TAVI): insights from the compulsory German quality assurance registry on aortic valve replacement (AQUA). EuroIntervention. 2017;13:914–20. PubMedCrossRef Bestehorn K, Eggebrecht H, Fleck E, Bestehorn M, Mehta RH, Kuck KH. Volume-outcome relationship with transfemoral transcatheter aortic valve implantation (TAVI): insights from the compulsory German quality assurance registry on aortic valve replacement (AQUA). EuroIntervention. 2017;13:914–20. PubMedCrossRef
34.
Zurück zum Zitat Inohara T, Hayashida K, Watanabe Y, Yamamoto M, Takagi K, Yashima F, et al. Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries. Catheter Cardiovasc Interv. 2016;87:963–70. PubMedCrossRef Inohara T, Hayashida K, Watanabe Y, Yamamoto M, Takagi K, Yashima F, et al. Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries. Catheter Cardiovasc Interv. 2016;87:963–70. PubMedCrossRef
35.
Zurück zum Zitat Eggebrecht H, Bestehorn M, Haude M, Schmermund A, Bestehorn K, Voigtlander T, et al. Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J. 2016;37:2240–8. PubMedCrossRef Eggebrecht H, Bestehorn M, Haude M, Schmermund A, Bestehorn K, Voigtlander T, et al. Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J. 2016;37:2240–8. PubMedCrossRef
36.
37.
Zurück zum Zitat Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, et al. Rupture of the device landing zone during transcatheter aortic valve implantation: a life-threatening but treatable complication. Circ Cardiovasc Interv. 2012;5:424–32. PubMedCrossRef Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, et al. Rupture of the device landing zone during transcatheter aortic valve implantation: a life-threatening but treatable complication. Circ Cardiovasc Interv. 2012;5:424–32. PubMedCrossRef
38.
Zurück zum Zitat Hamm CW, Mollmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, et al. The German aortic valve registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–98. PubMedCrossRef Hamm CW, Mollmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, et al. The German aortic valve registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–98. PubMedCrossRef
39.
Zurück zum Zitat Egger F, Zweiker D, Freynhofer MK, Loffler V, Rohla M, Geppert A, et al. Impact of on-site cardiac surgery on clinical outcomes after transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:2160–7. PubMedCrossRef Egger F, Zweiker D, Freynhofer MK, Loffler V, Rohla M, Geppert A, et al. Impact of on-site cardiac surgery on clinical outcomes after transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:2160–7. PubMedCrossRef
40.
Zurück zum Zitat Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra SA, Mavromatis K, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014;7:898–904. PubMedCrossRef Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra SA, Mavromatis K, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014;7:898–904. PubMedCrossRef
41.
Zurück zum Zitat Gurevich S, Oestreich B, Kelly RF, Mbai M, Bertog S, Ringsred K, et al. Outcomes of transcatheter aortic valve replacement using a minimalist approach. Cardiovasc Revasc Med. 2018;19:192–5. PubMedCrossRef Gurevich S, Oestreich B, Kelly RF, Mbai M, Bertog S, Ringsred K, et al. Outcomes of transcatheter aortic valve replacement using a minimalist approach. Cardiovasc Revasc Med. 2018;19:192–5. PubMedCrossRef
42.
Zurück zum Zitat Spaziano M, Lefevre T, Romano M, Eltchaninoff H, Leprince P, Motreff P, et al. Transcatheter aortic valve replacement in the catheterization laboratory versus hybrid operating room: insights from the FRANCE TAVI registry. JACC Cardiovasc Interv. 2018;11:2195–203. PubMedCrossRef Spaziano M, Lefevre T, Romano M, Eltchaninoff H, Leprince P, Motreff P, et al. Transcatheter aortic valve replacement in the catheterization laboratory versus hybrid operating room: insights from the FRANCE TAVI registry. JACC Cardiovasc Interv. 2018;11:2195–203. PubMedCrossRef
43.
Zurück zum Zitat Deharo P, Jaussaud N, Grisoli D, Camus O, Resseguier N, Le Breton H, et al. Impact of direct transcatheter aortic valve replacement without balloon aortic valvuloplasty on procedural and clinical outcomes: insights from the FRANCE TAVI registry. JACC Cardiovasc Interv. 2018;11:1956–65. PubMedCrossRef Deharo P, Jaussaud N, Grisoli D, Camus O, Resseguier N, Le Breton H, et al. Impact of direct transcatheter aortic valve replacement without balloon aortic valvuloplasty on procedural and clinical outcomes: insights from the FRANCE TAVI registry. JACC Cardiovasc Interv. 2018;11:1956–65. PubMedCrossRef
44.
Zurück zum Zitat Toggweiler S, Stortecky S, Holy E, Zuk K, Cuculi F, Nietlispach F, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv. 2016;9:1269–76. PubMedCrossRef Toggweiler S, Stortecky S, Holy E, Zuk K, Cuculi F, Nietlispach F, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv. 2016;9:1269–76. PubMedCrossRef
46.
Zurück zum Zitat von Scheidt W, et al. Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : joint consensus document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e. V. (ALKK) and cooperating cardiac surgery department. Clin Res Cardiol. 2020;109:1–12. CrossRef von Scheidt W, et al. Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : joint consensus document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e. V. (ALKK) and cooperating cardiac surgery department. Clin Res Cardiol. 2020;109:1–12. CrossRef
48.
Zurück zum Zitat Lamm G. New strategies in the management of valvular heart disease. Wien Klin Wochenschr. 2021. (submitted) Lamm G. New strategies in the management of valvular heart disease. Wien Klin Wochenschr. 2021. (submitted)
Metadaten
Titel
2020 update of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGHTG) on the position statement of the ÖKG and ÖGHTG for transcatheter aortic valve implantation 2011
verfasst von
Gudrun Lamm
Matthias Hammerer
Uta C. Hoppe
Martin Andreas
Rudolf Berger
Ronald K. Binder
Nikolaos Bonaros
Georg Delle-Karth
Matthias Frick
Michael Grund
Bernhard Metzler
Thomas Neunteufl
Philipp Pichler
Albrecht Schmidt
Wilfried Wisser
Andreas Zierer
Rainald Seitelberger
Michael Grimm
Alexander Geppert
ÖKG and ÖGHTG
Publikationsdatum
23.03.2021
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 15-16/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-021-01820-3